CC
PFE icon

ClearArc Capital’s Pfizer PFE Stock Holding History

ClearArc Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.02M Sell
54,405
-25,185
-32% -$897K 0.79% 28
2019
Q3 		$2.71M Buy
79,590
+43
+0.1% +$1.56K 0.78% 30
2019
Q2 		$3.27M Sell
79,547
-10,523
-12% -$418K 0.96% 22
2019
Q1 		$3.63M Sell
90,070
-6,557
-7% -$263K 0.98% 22
2018
Q4 		$4M Sell
96,627
-129,252
-57% -$5.37M 1.2% 12
2018
Q3 		$9.44M Buy
225,879
+53,295
+31% +$2.05M 1.24% 13
2018
Q2 		$5.94M Sell
172,584
-1,643
-0.9% -$56.1K 0.84% 26
2018
Q1 		$5.87M Buy
174,227
+575
+0.3% +$19.8K 0.89% 21
2017
Q4 		$5.97M Buy
173,652
+7,167
+4% +$244K 0.81% 33
2017
Q3 		$5.64M Sell
166,485
-18,392
-10% -$591K 0.85% 27
2017
Q2 		$5.89M Buy
184,877
+1,119
+0.6% +$35.3K 0.95% 21
2017
Q1 		$5.96M Sell
183,758
-1,523
-0.8% -$48K 0.99% 18
2016
Q4 		$5.71M Buy
185,281
+4,849
+3% +$148K 1.03% 19
2016
Q3 		$5.8M Buy
180,432
+3,868
+2% +$129K 1.09% 16
2016
Q2 		$5.9M Buy
176,564
+32
+0% +$1.02K 1.15% 16
2016
Q1 		$4.96M Buy
176,532
+1,719
+1% +$49.1K 1.05% 19
2015
Q4 		$5.35M Sell
174,813
-1,457
-0.8% -$45.8K 1.12% 13
2015
Q3 		$5.25M Buy
176,270
+1,045
+0.6% +$33.5K 1.09% 11
2015
Q2 		$5.57M Buy
175,225
+20,820
+13% +$679K 1.02% 15
2015
Q1 		$5.1M Buy
154,405
+14,239
+10% +$453K 1.05% 13
2014
Q4 		$4.14M Buy
140,166
+4,196
+3% +$120K 0.85% 17
2014
Q3 		$3.81M Sell
135,970
-1,162
-0.8% -$32.6K 0.86% 18
2014
Q2 		$3.86M Sell
137,132
-54,207
-28% -$1.55M 0.89% 21
2014
Q1 		$5.83M Buy
191,339
+8,752
+5% +$261K 1.44% 7
2013
Q4 		$5.31M Sell
182,587
-9,055
-5% -$264K 1.38% 9
2013
Q3 		$5.22M Sell
191,642
-12,981
-6% -$353K 1.46% 5
2013
Q2 		$5.44M Buy
+204,623
New +$5.65M 1.46% 7

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

ClearArc Capital's PFE Position: Q4 2019 in Review

ClearArc Capital reduced its Pfizer (PFE) stake by 32% in Q4 2019, selling an estimated $897K and leaving 54,405 shares worth $2.02M. The position accounts for 0.79% of the portfolio, ranked #28.

ClearArc Capital first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. The position peaked at $9.44M in Q3 2018. 2,525 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • ClearArc Capital held 54,405 shares of Pfizer worth $2.02M as of Q4 2019.
  • ClearArc Capital sold 25,185 Pfizer shares in Q4 2019, an estimated $897K.
  • Pfizer made up 0.79% of ClearArc Capital's portfolio in Q4 2019, its #28 holding.
  • ClearArc Capital first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Pfizer position peaked at $9.44M in Q3 2018.
  • 2,525 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.